Description
Lead the business management of a portfolio of precision oncology medicines for lung cancer from pre-launch stage onwards, ensuring robust pre-launch preparation, seamless launch readiness, integration into GSK systems, and strong in-market performance.
Asset & Portfolio Strategy (Pre-Launch to Post-Launch)
- Develop and maintain a clear business strategy and roadmap for lung cancer oncology assets, aligned with GSK's oncology growth ambitions and patient impact goals.
- Translate global and regional asset strategies into practical commercial plans, defining priorities, KPIs and performance targets across pre-launch, launch and post-launch phases.
Launch Readiness & Commercial Operations
- Partner with Regulatory, Market Access, Medical, Supply Chain to ensure end-to-end launch readiness, including access timelines, submission plans and payer engagement strategies.
- Support development and execution of access and reimbursement strategies for the new assets.
Stakeholder & Customer Coordination
- Act as a central coordination point between GSK and external partners, ensuring customer engagement remains clear and value-adding.
Performance Management & Business Analytics
- Track asset performance versus plan and provide regular business reviews and insights to leadership.
- Identify risks and opportunities across markets and recommend pragmatic actions to optimise impact and manage risk.
Risk & Issue Management
- Escalate material risks to appropriate governance forums, support mitigation planning, and communicate impacts to stakeholders.
Requirements
- University degree in Business, Life Sciences, Pharmacy, or related discipline; postgraduate qualification (MBA or equivalent) an advantage.
- Solid experience (typically 5+ years) in pharmaceutical business management, brand leadership, oncology and/or lung cancer experience strongly preferred.
- Strong strategic and analytical skills; able to connect scientific, commercial, operational and integration considerations into clear business decisions for oncology lung cancer assets.
- Excellent cross-functional leadership and programme management capabilities, comfortable operating in highly matrixed and evolving environments.
- Clear, confident communication and influencing skills with senior stakeholders, field teams and external partners.
- High resilience, pragmatism and problem-solving mindset, with strong focus on patient impact and business continuity.